IPL commissioner Lalit Modi confirmed on Sunday that a player tested positive for a banned substance during the first edition of the tournament, but did not reveal who it was.

However, Asif, who played for the Delhi Daredevils, was named in a statement from the IPL on Monday as the player in question.

The statement read: "The Indian Premier League compared the result from the WADA-approved laboratory in Switzerland with the data collected by IDTM, the Sweden-based independent agency which organised the anti-doping testing in accordance with World Anti-Doping Agency (WADA) standards, to confirm the player in violation is Mr Mohammad Asif."

It continued: "It was also checked if Mr Mohammad Asif had applied for and was granted a Therapeutic Use Exemption (TUE). It was found that Mr Mohammad Asif had not applied for a TUE.

"A note in writing has been sent to the player and his home board and to the franchisee on the findings."

Asif can ask for a B sample to be analysed.

The player, along with his representatives, will have the right to attend the opening of the B sample should they choose to follow that route, with the results to be referred to a three-man IPL Drug Tribunal.